Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Sensitivity in Adults With Treated and Untreated Obstructive Sleep Apnea
NCT02898792Phase 1Completed
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2016
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of remifentanil in pain, sponsored by Washington University School of Medicine. Primary endpoint: Pupil diameter change at 50 months. Started Sep 2016; status: completed.
02
Drugs
remifentanil
03
Conditions
pain
Beyond the preview
Go deeper on NCT02898792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02898792.